Australia’s Symbion Recommends Acceptance Of Primary Acquisition Offer
This article was originally published in PharmAsia News
Australia's health care giant, Symbion Health, now recommends its shareholders accept a $2.4 billion acquisition try by Primary Health Care after the buyer said its bid was unconditional. Primary said in an official notice it now has 53.8 percent of Symbion's voting shares. Primary's offer for more shares is expected to close Feb. 21, when the buyers begin considering whether to divest some of Symbion's assets. (Click here for more
You may also be interested in...
Teligent has achieved a “pivotal step in our journey toward securing a strong financial future,” according to management, after recapitalizing its significant debt burden and gaining access to more cash.
Pfizer has entered into an agreement with Premier to supply five essential medications to US healthcare providers through Premier’s ProvideGx program. Both companies aim to secure supply of products specifically used by COVID patients.
Announcing his “first step to take on pricing of generic drugs,” billionaire Mark Cuban recently associated his name with a new US generics company “to show that capitalism can be compassionate.” In an exclusive chat with Generics Bulletin, the newly established company’s CEO Alex Oshmyansky revealed that they started working on the company “in stealth” since 2018.